StockData
Talphera, Inc. logo

Talphera, Inc. (TLPH) stock

TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.80−0.06 (-6.98%)

Close on Nov 17, 2026Market cap $41.57MP/E –Yield –

Talphera operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Talphera's operating income for the twelve months ending Jun 30, 2026 was -$14.75M. For fiscal 2025 it was -$13.48M. The highest annual figure on record is -$6.67M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.48M–
FY2024Dec 31, 2024-$15.25M–
FY2023Dec 31, 2023-$16.89M–
FY2022Dec 31, 2022-$25.30M–
FY2021Dec 31, 2021-$35.97M–
FY2020Dec 31, 2020-$40.96M–
FY2019Dec 31, 2019-$54.21M–
FY2018Dec 31, 2018-$35.73M–
FY2017Dec 31, 2017-$38.68M–
FY2016Dec 31, 2016-$31.96M–
FY2015Dec 31, 2015-$19.95M–
FY2014Dec 31, 2014-$37.65M–
FY2013Dec 31, 2013-$6.67M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.92M–
Q1 FY2026Mar 31, 2026-$3.95M–
Q4 FY2025Dec 31, 2025-$3.45M–
Q3 FY2025Sep 30, 2025-$3.42M–
Q2 FY2025Jun 30, 2025-$3.69M–
Q1 FY2025Mar 31, 2025-$2.92M–
Q4 FY2024Dec 31, 2024-$3.00M-176.8%
Q3 FY2024Sep 30, 2024-$3.75M–
Q2 FY2024Jun 30, 2024-$4.27M–
Q1 FY2023Mar 31, 2023-$5.33M–
Q4 FY2022Dec 31, 2022$3.90M–
Q3 FY2022Sep 30, 2022-$6.63M–
Q2 FY2022Jun 30, 2022-$13.57M–
Q1 FY2022Mar 31, 2022-$4.94M–
Q4 FY2021Dec 31, 2021-$8.18M–
Q3 FY2021Sep 30, 2021-$8.63M–
Q2 FY2021Jun 30, 2021-$10.02M–
Q1 FY2021Mar 31, 2021-$9.14M–
Q4 FY2020Dec 31, 2020-$9.24M–
Q3 FY2020Sep 30, 2020-$9.04M–
Q2 FY2020Jun 30, 2020-$6.83M–
Q1 FY2020Mar 31, 2020-$15.85M–
Q4 FY2019Dec 31, 2019-$14.99M–
Q3 FY2019Sep 30, 2019-$13.53M–
Q2 FY2019Jun 30, 2019-$13.36M–
Q1 FY2019Mar 31, 2019-$12.32M–
Q4 FY2018Dec 31, 2018-$10.98M–
Q3 FY2018Sep 30, 2018-$9.33M–
Q2 FY2018Jun 30, 2018-$7.15M–
Q1 FY2018Mar 31, 2018-$8.27M–
Q4 FY2017Dec 31, 2017-$7.81M–
Q3 FY2017Sep 30, 2017-$8.86M–
Q2 FY2017Jun 30, 2017-$9.94M–
Q1 FY2017Mar 31, 2017-$12.07M–
Q4 FY2016Dec 31, 2016-$7.14M–
Q3 FY2016Sep 30, 2016-$7.98M–

More Talphera figures

See a number that looks wrong?